Navigation Links
Fate Therapeutics' iPSC Technology Awarded Top Industry Honors for Small Molecule and Protein Reprogramming Breakthroughs
Date:12/21/2009

ethod to recapitulate human physiology for commercial scale drug discovery and therapeutic use. The Company has exclusively in-licensed from The Scripps Research Institute and the Whitehead Institute for Biomedical Research an intellectual property portfolio related to iPSC technology, including filings that date back to November 2003. This portfolio includes the latest techniques published by Dr. Sheng Ding in October 2009, which use three small molecules to generate iPSCs in a manner that is 200 times more efficient than and twice as fast as conventional methods for reprogramming adult human cells.

"Without using dangerous genetic manipulations associated with other methods of reprogramming, Fate Therapeutics has created a powerful platform for safer, more efficient reprogramming of human somatic cells," said Sandhya Kamath, senior research analyst at Frost & Sullivan. "Its protein-only approach to iPSC generation represents a true paradigm shift in reprogramming technology. By maintaining genetic fidelity, biologically-relevant model systems may be created to better understand diseases and to elucidate molecular targets for drug discovery."

In addition to establishing the leading industrialized platform for iPSC technology, Fate Therapeutics is advancing its pipeline of stem cell modulators, which includes FT1050 for the enhancement of hematopoietic stem cell (HSC) proliferation and homing. The small molecule is currently undergoing clinical testing at the Dana Farber Cancer Institute and Massachusetts General Hospital in adult patients with hematologic malignancies, such as leukemia and lymphoma, who have undergone nonmyeloablative conditioning therapy and are in need of HSC support. The Phase 1b study is intended to determine the safety and tolerability of introducing FT1050 during the standard course of dual umbilical cord blood transplant.

About The Scientist's "Top 10 Innovations" List

The Scientist
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)
2. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
3. Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 10, 2010
4. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
5. Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
6. Oxygen Biotherapeutics, Inc. Expands Board of Directors
7. Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign
8. Drug Candidates in Pipeline Offer Potential for Parkinsons Disease Therapeutics Market, Says Frost & Sullivan
9. Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy
10. Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing
11. Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  Lazarus Effect, a medical device company focused ... facilitate removal of blood clots, announced today that ... issued a new patent (U.S. Patent Number 8,795,305) ... TM and ReCover TM devices. ... stent-retriever (stentriever) with an integrated, novel, cover-based protection ...
(Date:7/24/2014)... , July 24, 2014 Consolidated Net ... Business Highlights   , India Business grew ... by 9.33% to Rs. 4,886.70 Mn Rest of World ... Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn ... , Glenmark Pharmaceuticals Limited, the research-led global ...
(Date:7/24/2014)... -- In any given hospital in the country at any ... one hospital-acquired infection, according to the Centers of Disease ... prove fatal. And as increased surveillance has shown that ... per year, infection control efforts have drifted to the ... stronger emphasis is being placed upon innovative and comprehensive ...
Breaking Medicine Technology:Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3
...  Medtronic, Inc, one of the world,s largest medical device ... U.S. Department of Justice (DOJ), the Office of the ... Services, and four relators in a qui tam suit ... in the U.S., including pacemakers and implantable cardioverter defibrillators ...
... A three-drug combination treatment for the blood cancer multiple myeloma ... patients, according to a multi-center study led by Andrzej ... the multiple myeloma program at the University of Chicago Medical ... of the phase I-II study on Dec. 12, 2011, ...
Cached Medicine Technology:Settlement Announced in Medtronic Qui Tam Case 2Drug Combination Highly Effective for Newly Diagnosed Myeloma Patients, Study Finds 2Drug Combination Highly Effective for Newly Diagnosed Myeloma Patients, Study Finds 3
(Date:7/24/2014)... The report, “Content Delivery Networks (CDN) Market”, defines ... with an in-depth analysis and forecasting of revenues. ... this market with insights on trends, opportunities, and ... 36 figures spread through 157 pages and in-depth ... http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html . , Early buyers will ...
(Date:7/24/2014)... In a July 9th article in the Money magazine ... Blossom Consulting LLC , was quoted in a Family Finance ... the High Cost of Infertility . Her advice began with, ... your chance of success from the first attempt.” The article ... “I am always happy to talk with the media about ...
(Date:7/24/2014)... Kathleen Doheny HealthDay Reporter ... children often don,t view their kids as unhealthy or recognize ... a new study. The children of the families surveyed ... the Hasbro Children,s Hospital in Providence, R.I. "A third ... study researcher Dr. Kyung Rhee, now an assistant professor of ...
(Date:7/24/2014)... care treatment of overweight and obese preschoolers works better ... when only the child is targeted, according to research ... at the University at Buffalo and Women and Children,s ... overweight or obese and had one parent who participated ... according to body mass index (BMI) measurements, calculated based ...
(Date:7/24/2014)... like a medical device or surgical implant is put ... to Northwestern University,s Guillermo Ameer, most of the time, ... function. , "You will always get an inflammatory response ... in Northwestern,s McCormick School of Engineering and Applied Science ... Medicine. "A problem with commonly used plastic materials, in ...
Breaking Medicine News(10 mins):Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 2Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 3Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:Overweight and obese preschoolers lose more weight when parent is also treated 2Health News:Overweight and obese preschoolers lose more weight when parent is also treated 3Health News:Antioxidant biomaterial promotes healing 2
... , WEDNESDAY, Sept. 21 (HealthDay News) -- How ... they see a pediatrician, dermatologist or internist, a new ... birth to age 18 are affected by psoriasis, a ... flaky, dry skin. Researchers from University of California, ...
... 21, 2011) A soy germ-based nutritional supplement containing ... skin wrinkles of the outer corner of the eyes ... S-equol have potential to slow skin aging, according to ... in the peer-review journal Menopause and presented ...
... America (ASA) will include more than 1,000 presentations in the ... speech; the science of music; the impact of noise on ... irritating impacts the way we learn, work, and play. ... place October 31 - November 4 in San Diego, California, ...
... (HealthDay News) -- Most of the 220,000 people who undergo ... follow-up procedures they could have to remove any loose skin ... surgeons. However, not all patients who undergo so-called ... dramatic weight loss, said one doctor who,s an obesity expert. ...
... whose work is advancing understanding of neurodegenerative diseases, has ... highest honors bestowed on an individual in the United ... of neurology in the UCSF Memory and Aging Center, ... dementia, a family of neurological syndromes usually afflicting ...
... can invade your bloodstream, break into your brain and ... contagious protozoa infect more than half the world,s population, ... Cornell researchers recently discovered how T. gondii ... it the first known parasite to control its host,s ...
Cached Medicine News:Health News:Kids With Psoriasis Get Inconsistent Care 2Health News:Soy-based natural S-equol supplements improve crow's feet skin wrinkles in menopausal women 2Health News:Soy-based natural S-equol supplements improve crow's feet skin wrinkles in menopausal women 3Health News:Acoustical Society meeting: Highlights and media registration 2Health News:Acoustical Society meeting: Highlights and media registration 3Health News:Acoustical Society meeting: Highlights and media registration 4Health News:Acoustical Society meeting: Highlights and media registration 5Health News:Acoustical Society meeting: Highlights and media registration 6Health News:Many Unaware of Plastic Surgery Options After Weight Loss Procedures 2Health News:UCSF neurologist William Seeley, M.D., named MacArthur Fellow 2Health News:UCSF neurologist William Seeley, M.D., named MacArthur Fellow 3Health News:UCSF neurologist William Seeley, M.D., named MacArthur Fellow 4Health News:Researchers discover how 'promiscuous parasites' hijack host immune cells 2Health News:Researchers discover how 'promiscuous parasites' hijack host immune cells 3
Reliable and Affordable. The Schuco 3000 Nebulizer by Allied has been designed to offer a compact style that provides worry-free affordable nebulizer therapy....
... CNBT technology, which relieves the practitioner of the ... HOPE allows you the ability to mix medications ... be easier, with a length of oxygen tubing ... the HOPE nebulizer into an inexpensive alternative to ...
... utilizing Vibrating Mesh Technology to efficiently ... from Asthma, COPD or other respiratory ... size and handy carrying case that ... them. Powerful delivery comparable to table-top ...
... dilution nebulizer allows the clinician to deliver up ... into the side port for precise high flow ... for normal flow patients, delivers 8-12 lpm in ... side port. For your high flow needs, DHD ...
Medicine Products: